Medpace Holdings, Inc. Revenue from Related Parties
Medpace Holdings, Inc. (MEDP) reported Revenue from Related Parties of $15.80 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-04-25.
Discontinued › Income Statement › Other Income
us-gaap:RevenueFromRelatedParties · last filed 2023-04-25
- Medpace Holdings, Inc. revenue from related parties for the quarter ending 2023-03-31 was $15.80M, a 18.80% increase year-over-year.
- Medpace Holdings, Inc. revenue from related parties for the quarter ending 2022-12-31 was $15.10M, a 42.45% increase year-over-year.
- Medpace Holdings, Inc. revenue from related parties for the quarter ending 2022-09-30 was $9.80M, a 12.64% increase year-over-year.
- Medpace Holdings, Inc. revenue from related parties for the quarter ending 2022-06-30 was $17.20M.
- Medpace Holdings, Inc. revenue from related parties for fiscal 2022 was $55.40M, a 60.58% increase from fiscal 2021.
- Medpace Holdings, Inc. revenue from related parties for fiscal 2021 was $34.50M, a 116.98% increase from fiscal 2020.
- Medpace Holdings, Inc. revenue from related parties for fiscal 2020 was $15.90M.
- Medpace Holdings, Inc. revenue from related parties for fiscal 2017 was $11.10M, a 53.94% decline from fiscal 2016.
| Period end | Revenue from Related Parties 3 month | Revenue from Related Parties 6 month | Revenue from Related Parties 9 month | Revenue from Related Parties 12 month |
|---|---|---|---|---|
| 2023-03-31 | $15.80M 10-Q · filed 2023-04-25 | $30.90M derived: sum of 2 quarters · filed 2023-04-25 | $40.70M derived: sum of 3 quarters · filed 2023-04-25 | $57.90M derived: sum of 4 quarters · filed 2023-04-25 |
| 2022-12-31 | $15.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $24.90M derived: sum of 2 quarters · filed 2023-02-14 | $42.10M derived: sum of 3 quarters · filed 2023-02-14 | $55.40M 10-K · filed 2023-02-14 |
| 2022-09-30 | $9.80M 10-Q · filed 2022-10-25 | $27.00M derived: sum of 2 quarters · filed 2023-02-14 | $40.30M 10-Q · filed 2022-10-25 | $50.90M derived: sum of 4 quarters · filed 2023-04-25 |
| 2022-06-30 | $17.20M derived: 10-K 12 month − 3 quarters · filed 2023-02-14 | $30.50M derived: sum of 2 quarters · filed 2023-04-25 | $41.10M derived: sum of 3 quarters · filed 2023-04-25 | $49.80M derived: sum of 4 quarters · filed 2023-04-25 |
| 2022-03-31 | $13.30M 10-Q · filed 2023-04-25 | $23.90M derived: sum of 2 quarters · filed 2023-04-25 | $32.60M derived: sum of 3 quarters · filed 2023-04-25 | |
| 2021-12-31 | $10.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $19.30M derived: sum of 2 quarters · filed 2023-02-14 | $34.50M 10-K · filed 2023-02-14 | |
| 2021-09-30 | $8.70M 10-Q · filed 2022-10-25 | $23.90M 10-Q · filed 2022-10-25 | ||
| 2020-12-31 | $15.90M 10-K · filed 2023-02-14 | |||
| 2017-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $4.20M derived: sum of 2 quarters · filed 2018-02-27 | $7.10M derived: sum of 3 quarters · filed 2018-02-27 | $11.10M 10-K · filed 2018-02-27 |
| 2017-09-30 | $2.00M 10-Q · filed 2017-10-31 | $4.90M derived: sum of 2 quarters · filed 2017-10-31 | $8.90M 10-Q · filed 2017-10-31 | $13.70M derived: sum of 4 quarters · filed 2018-02-27 |
| 2017-06-30 | $2.90M 10-Q · filed 2017-08-01 | $6.90M 10-Q · filed 2017-08-01 | $11.70M derived: sum of 3 quarters · filed 2018-02-27 | $18.60M derived: sum of 4 quarters · filed 2018-02-27 |
| 2017-03-31 | $4.00M 10-Q · filed 2017-05-02 | $8.80M derived: sum of 2 quarters · filed 2018-02-27 | $15.70M derived: sum of 3 quarters · filed 2018-02-27 | $20.30M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-12-31 | $4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $11.70M derived: sum of 2 quarters · filed 2018-02-27 | $16.30M derived: sum of 3 quarters · filed 2018-02-27 | $24.10M 10-K · filed 2018-02-27 |
| 2016-09-30 | $6.90M 10-Q · filed 2017-10-31 | $11.50M derived: sum of 2 quarters · filed 2017-10-31 | $19.30M 10-Q · filed 2017-10-31 | $25.70M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $4.60M 10-Q · filed 2017-08-01 | $12.40M 10-Q · filed 2017-08-01 | $18.80M derived: sum of 3 quarters · filed 2018-02-27 | $24.90M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $7.80M 10-Q · filed 2017-05-02 | $14.20M derived: sum of 2 quarters · filed 2018-02-27 | $20.30M derived: sum of 3 quarters · filed 2018-02-27 | |
| 2015-12-31 | $6.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $12.50M derived: sum of 2 quarters · filed 2018-02-27 | $24.00M 10-K · filed 2018-02-27 | |
| 2015-09-30 | $6.10M 10-Q · filed 2016-11-03 | $17.60M 10-Q · filed 2016-11-03 | ||
| 2014-12-31 | $11.80M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |